Studies with human thyroid tumors have suggested that the invasion and metastasis of FTC, as activated by this pathway, mainly affect activation and nuclear localization of Akt1, which coincides with the presence of Akt1 mutations in the metastatic thyroid cancers. The gene discussed is AKT1; the disease is thyroid tumor.